New publication about applications of Attana's cell-based technology for characterization of drug molecules interaction with therapeutic receptors

Johan Rockberg and Johan Nilvebrant at KTH in Stockholm have edited a new book "Epitope Mapping Protocols", which describes different methods to optimize antibodies properties to identify and interact with receptors in the body for pharmaceutical and diagnostic applications. In the chapter "Label-Free Cell-Based Assay for Characterization of Biomolecules and Receptors"  illustrates the use of Attana's cell based technology within those areas.


Thanks to antibodies good properties to selective interact with target molecules in the body and with few off-target interactions, they are used within therapeutic, diagnostic and research applications. During development of new antibodies different technologies are applied to optimize properties such as selectivity and interaction strength. The book describes the state of the art technologies and Attana was invited to write the chapter about cell-based interaction studies. The advantage of the Attana technology is that it mimics natural conditions well and thereby provide information about the dynamics and complexity of the interaction between the drug molecules and their receptors and thus is a valuable tool for selection and optimization of the right molecules.

For more information, please contact:

Teodor Aastrup, CEO Attana AB
e-mail: teodor.aastrup@attana.com 
tel: + 46 8 674 57 00

The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share prices, but is of general interest for the shareholders and hence should be communicated.

Attana was founded in 2002 with the vision of in-vitro characterization of molecular interactions mimicking in-vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays. Attana’s products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences.  To learn more about Attana’s contract research services and our label free cell-based biosensors, please visit www.attana.com or contact  sales@attana.com

Tags:

About Us

Attana was founded in 2002 with the vision of in-vitro characterization of molecular interactions mimicking in-vivo conditions. Since then, Attana has developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays. Attana’s products and research services are used by Big Pharma, biotech companies and academic institutions within the life sciences. To learn more about Attana’s contract research services and our label free cell-based biosensors, please visit www.attana.com or contact sales@attana.com.

Subscribe

Media

Media

Documents & Links